Several medical interest groups have raised their opposition to the new Republican plan drafted to replace the Affordable Care Act.
The American Medical Association (AMA) and the American Hospital Association (AHA) have openly raised concerns with the proposals within the American Health Care Act (AHCA) that was released by House Republicans earlier this week.
The House Energy and Commerce and Ways and Means Committees, which were responsible for drafting the bill, received a letter from the AMA that stated that the current draft of the AHCA would not just reduce insurance coverage, but would also cause harm to vulnerable populations in need of healthcare services. In their letter, the AMA raised concerns with:
Acknowledging the need to address some of the problems within the ACA, the letter urged the members of the 2 committees to ensure that “low and moderate income Americans will be able to secure affordable and adequate coverage and that Medicaid, CHIP, and other safety net programs are maintained and adequately funded.”
A similar letter was drafted by the AHA, asking the Congress to halt formal voting on the bill until the Congressional Budget Office provides a score on the coverage estimates. AHA has also raised concerns with the Medicaid restructure and reduction in payments for hospital services. With an appeal to Congress to guarantee coverage to as many Americans as possible, AHA, which represents all major hospitals and health systems, wrote, “It is critical that this process be thoughtful and focused on finding ways to improve our health care system, particularly for the poor, elderly and disabled.”
The American Association of Retired Persons (AARP) has estimated that if the bill becomes law, a 55-year old with an annual income of $25,000 would see a premium increase of at least $2300. A 64-year old in the same income bracket would see a premium spike of at least $4400 annually, while a 64-year old earning $15,000 would spend more than $5800.
The bill has also drawn opposition from other groups, including the American Academy of Pediatrics, the American Psychiatric Association, and the Federation of American Hospitals.
Meanwhile, the House Ways and Means Committee cleared the AHCA in a predawn, party line vote earlier today.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
April 15th 2025Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Read More
Lifestyle Interventions, Statins, Among Keys to Mitigating CVD Risk in MASLD/MASH
April 15th 2025A recent review highlights the gaps in clinical guidelines and treatment approaches for metabolic dysfunction-associated steatohepatitis (MASH) and looks ahead to the future promise of glucagon-like peptide 1 (GLP-1) receptor agonists for liver conditions.
Read More